Mahsa Dadar

Dr. Mahsa Dadar

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FMFilip Morys
Filip Morys
MDMahsa Dadar
Mahsa Dadar
ADAlain Dagher
Alain Dagher
Context Chronic obesity is associated with several complications, including cognitive impairment and dementia. However, we have only piecemeal knowledge of the mechanisms linking obesity to central nervous system damage. Among candidate mechanisms are other elements of obesity-associated metabolic syndrome, such as hypertension, dyslipidemia, and diabetes, but also systemic inflammation. While there have been several neuroimaging studies linking adiposity to changes in brain morphometry, a comprehensive investigation of the relationship has so far not been done. Objective To identify links between adiposity and cognitive dysfunction. Methods This observational cohort study (UK Biobank), with an 8-year follow-up, included more than 20 000 participants from the general community, with a mean age of 63 years. Only participants with data available on both baseline and follow-up timepoints were included. The main outcome measures were cognitive performance and mediator variables: hypertension, diabetes, systemic inflammation, dyslipidemia, gray matter measures, and cerebrovascular disease (volume of white matter hyperintensities on magnetic resonance imaging). Results Using structural equation modeling, we found that body mass index, waist-to-hip ratio, and body fat percentage were positively related to higher plasma C-reactive protein, dyslipidemia, hypertension, and diabetes. In turn, hypertension and diabetes were related to cerebrovascular disease. Finally, cerebrovascular disease was associated with lower cortical thickness and volume and higher subcortical volumes, but also cognitive deficits (largest significant pcorrected = 0.02). Conclusions We show that adiposity is related to poor cognition, with metabolic consequences of obesity and cerebrovascular disease as potential mediators. The outcomes have clinical implications, supporting a role for the management of adiposity in the prevention of late-life dementia and cognitive decline.

1 January 2018 in NeuroImage: Clinical
Verified
Journal Article
Open access
JMJosé María Mateos-Pérez
José María Mateos-Pérez
MDMahsa Dadar
Mahsa Dadar
MLMaría Lacalle-Aurioles
María Lacalle-Aurioles
YIYasser Iturria-Medina
Yasser Iturria-Medina
YZYashar Zeighami
Yashar Zeighami
AEAlan C. Evans
Alan C. Evans
In this paper, we provide an extensive overview of machine learning techniques applied to structural magnetic resonance imaging (MRI) data to obtain clinical classifiers. We specifically address practical problems commonly encountered in the literature, with the aim of helping researchers improve the application of these techniques in future works. Additionally, we survey how these algorithms are applied to a wide range of diseases and disorders (e.g. Alzheimer's disease (AD), Parkinson's disease (PD), autism, multiple sclerosis, traumatic brain injury, etc.) in order to provide a comprehensive view of the state of the art in different fields.

1 July 2018 in NeuroImage
Verified
Journal Article
Closed access
MDMahsa Dadar
Mahsa Dadar
VFVladimir S. Fonov
Vladimir S. Fonov
DCD. Louis Collins
D. Louis Collins

1 August 2017 in NeuroImage
Verified
Journal Article
Closed access
MDMahsa Dadar
Mahsa Dadar
JMJosefina Maranzano
Josefina Maranzano
KMKaren Misquitta
Karen Misquitta
CACassandra J. Anor
Cassandra J. Anor
VFVladimir S. Fonov
Vladimir S. Fonov
DCD. Louis Collins
D. Louis Collins

12 April 2017 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
MDMahsa Dadar
Mahsa Dadar
TPTharick A. Pascoal
Tharick A. Pascoal
SMSarinporn Manitsirikul
Sarinporn Manitsirikul
KMKaren Misquitta
Karen Misquitta
VFVladimir S. Fonov
Vladimir S. Fonov
DCD. Louis Collins
D. Louis Collins
Segmentation and volumetric quantification of white matter hyperintensities (WMHs) is essential in assessment and monitoring of the vascular burden in aging and Alzheimer's disease (AD), especially when considering their effect on cognition. Manually segmenting WMHs in large cohorts is technically unfeasible due to time and accuracy concerns. Automated tools that can detect WMHs robustly and with high accuracy are needed. Here, we present and validate a fully automatic technique for segmentation and volumetric quantification of WMHs in aging and AD. The proposed technique combines intensity and location features from multiple magnetic resonance imaging contrasts and manually labeled training data with a linear classifier to perform fast and robust segmentations. It provides both a continuous subject specific WMH map reflecting different levels of tissue damage and binary segmentations. The method was used to detect WMHs in 80 elderly/AD brains (ADC data set) as well as 40 healthy subjects at risk of AD (PREVENT-AD data set). Robustness across different scanners was validated using ten subjects from ADNI2/GO study. Voxel-wise and volumetric agreements were evaluated using Dice similarity index (SI) and intra-class correlation (ICC), yielding ICC = 0.96, SI = 0.62±0.16 for ADC data set and ICC = 0.78, SI = 0.51 ± 0.15 for PREVENT-AD data set. The proposed method was robust in the independent sample yielding SI = 0.64 ± 0.17 with ICC = 0.93 for ADNI2/GO subjects. The proposed method provides fast, accurate, and robust segmentations on previously unseen data from different models of scanners, making it ideal to study WMHs in large scale multi-site studies.

27 November 2017 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
MDMahsa Dadar
Mahsa Dadar
JMJosefina Maranzano
Josefina Maranzano
SDSimon Ducharme
Simon Ducharme
OCOwen T. Carmichael
Owen T. Carmichael
CDCharles Decarli
Charles Decarli
AIAlzheimer'S Disease Neuroimaging Initiative
Alzheimer'S Disease Neuroimaging Initiative